Sarepta (SRPT) Wins Key PTO Decision on Composition of Matter Patents - Oppenheimer
Go back to Sarepta (SRPT) Wins Key PTO Decision on Composition of Matter Patents - Oppenheimer| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 56.60 +0.70 (1.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.90 | 52 Week High | $108.96 | |||
| Open | $55.80 | 52 Week Low | $62.12 | |||
| Day High | $56.73 | P/E | N/A | |||
| Day Low | $55.74 | EPS | $-1.27 | |||
| Volume | 163,884 | |||||
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 17.38 -0.27 (1.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.65 | 52 Week High | $63.73 | |||
| Open | $17.33 | 52 Week Low | $8.00 | |||
| Day High | $17.80 | P/E | N/A | |||
| Day Low | $17.33 | EPS | $-5.69 | |||
| Volume | 371,368 | |||||
